Sara Brenner moves from CDHR to acting FDA commissioner

Sara Brenner has become acting commissioner of FDA, according to the agency’s website, in a change made Friday afternoon when Sara Brenner’s title was changed from principal deputy commissioner to acting commissioner. Before taking control of the agency, she held was CMO for in vitro diagnostics and associate director for medical affairs at the Center for Devices and Radiological Health.

After nearly five years investing at Swiss VC +ND Capital, Dani Bach has joined Lausanne, Switzerland-based advisory firm Limani Partners as managing director...